Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Fassan

Showing results (561-570 of 596) with videos related to

Pageof 60
Sort By:
The Lancet. Oncology|November 18, 2024
Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy in patients with advanced HER2-negative gastric or gastro-oesophageal junction cancer (ARMANI): a randomised, open-label, multicentre, phase 3 trialGiovanni Randon, Sara Lonardi, Matteo Fassan, et al.
Journal for Immunotherapy of Cancer|January 13, 2022
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancerFrancesco De Sanctis, Alessia Lamolinara, Federico Boschi, et al.
Cell|April 2, 2026
A 3D morphogenetic blueprint for metastatic outgrowth in breast cancerRobin Caire, Roberta Bordo, Francesca Zanconato, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 24, 2023
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive CellsMichele Simbolo, Nicola Silvestris, Giuseppe Malleo, et al.
Gut|November 17, 2020
EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancersElizabeth C Smyth, Georgios Vlachogiannis, Somaieh Hedayat, et al.
Liver Cancer|December 24, 2025
Vessels That Encapsulate Tumor Cluster+ Unresectable Hepatocellular Carcinomas Benefit of Antiangiogenic TherapyCamilla De Carlo, Reha Akpinar, Barbara Durante, et al.
Gastroenterology|November 9, 2017
MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in CholangiocarcinomaAndrea Lampis, Pietro Carotenuto, Georgios Vlachogiannis, et al.
Cancer Cell|April 17, 2014
MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancerNicola Valeri, Chiara Braconi, Pierluigi Gasparini, et al.
Cancer Discovery|September 1, 2018
Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical TrialKhurum H Khan, David Cunningham, Benjamin Werner, et al.
Hepatology (Baltimore, Md.)|December 28, 2019
Modulation of Biliary Cancer Chemo-Resistance Through MicroRNA-Mediated Rewiring of the Expansion of CD133+ CellsPietro Carotenuto, Somaieh Hedayat, Matteo Fassan, et al.
Pageof 60

Showing results (561-570 of 596) with videos related to

Sort By:
Pageof 60
The Lancet. Oncology|November 18, 2024
Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy in patients with advanced HER2-negative gastric or gastro-oesophageal junction cancer (ARMANI): a randomised, open-label, multicentre, phase 3 trialGiovanni Randon, Sara Lonardi, Matteo Fassan, et al.
Journal for Immunotherapy of Cancer|January 13, 2022
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancerFrancesco De Sanctis, Alessia Lamolinara, Federico Boschi, et al.
Cell|April 2, 2026
A 3D morphogenetic blueprint for metastatic outgrowth in breast cancerRobin Caire, Roberta Bordo, Francesca Zanconato, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 24, 2023
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive CellsMichele Simbolo, Nicola Silvestris, Giuseppe Malleo, et al.
Gut|November 17, 2020
EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancersElizabeth C Smyth, Georgios Vlachogiannis, Somaieh Hedayat, et al.
Liver Cancer|December 24, 2025
Vessels That Encapsulate Tumor Cluster+ Unresectable Hepatocellular Carcinomas Benefit of Antiangiogenic TherapyCamilla De Carlo, Reha Akpinar, Barbara Durante, et al.
Gastroenterology|November 9, 2017
MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in CholangiocarcinomaAndrea Lampis, Pietro Carotenuto, Georgios Vlachogiannis, et al.
Cancer Cell|April 17, 2014
MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancerNicola Valeri, Chiara Braconi, Pierluigi Gasparini, et al.
Cancer Discovery|September 1, 2018
Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical TrialKhurum H Khan, David Cunningham, Benjamin Werner, et al.
Hepatology (Baltimore, Md.)|December 28, 2019
Modulation of Biliary Cancer Chemo-Resistance Through MicroRNA-Mediated Rewiring of the Expansion of CD133+ CellsPietro Carotenuto, Somaieh Hedayat, Matteo Fassan, et al.
Pageof 60